| Mckay Herpel, PHARMD | |
|
100 E Idaho St, Boise, ID 83712-6267 | |
| (208) 381-3108 | |
| Not Available |
| Full Name | Mckay Herpel |
|---|---|
| Gender | Male |
| Speciality | Pharmacist - Oncology |
| Location | 100 E Idaho St, Boise, Idaho |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013680412 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 03440058 (Ohio) | Secondary |
| 1835X0200X | Pharmacist - Oncology | P9366 (Idaho) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mckay Herpel, PHARMD 3213 W Bellomy Ln, Boise, ID 83703-5311 Ph: (435) 668-8150 | Mckay Herpel, PHARMD 100 E Idaho St, Boise, ID 83712-6267 Ph: (208) 381-3108 |
News Archive
Following careful review and deliberation, the U.S. Food and Drug Administration is taking important steps that will allow a critically needed supply of the Janssen (Johnson & Johnson) COVID-19 Vaccine to be made available.
Structural cardiovascular abnormalities present at birth are the leading cause of heart failure in children. Nearly half a million children in the United States have structural heart problems ranging in severity from relatively simple issues, such as small holes between chambers of the heart, to very severe malformations, including complete absence of one or more chambers or valves.
Vaxin Inc., a privately-held biotechnology company, has demonstrated, in a Phase I human clinical study, that the company's recombinant influenza vaccine provides a potential alternative to traditional flu vaccines.
A new study addresses an urgent need – namely, a therapeutic antibody directed specifically against a key SARS-CoV-2 antigen which is highly conserved among similar viruses, and is not easily bypassed by viral escape mutations.
Dipexium Pharmaceuticals, Inc., a late-stage pharmaceutical company focused on the development and commercialization of Locilex® (pexiganan cream 0.8%), a novel, broad spectrum, topical antibiotic peptide, today announced operational, clinical and financial results for the year ended December 31, 2014.
› Verified 7 days ago
Eleanor I Evans, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5005 W Overland Rd, Boise, ID 83705 Phone: 208-389-1448 Fax: 208-389-1458 | |
Ms. Fatima Walizada, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5005 W Overland Rd, Boise, ID 83705 Phone: 208-389-1448 | |
David Lyn Harrison, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 9196 W Emerald St, Suite 110, Boise, ID 83704 Phone: 208-323-1259 Fax: 208-323-5666 | |
Mary Gobeille, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5230 W Franklin Rd, Boise, ID 83705 Phone: 208-429-6433 | |
Megan B Seewald, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3233 N Cole Rd, Boise, ID 83704 Phone: 208-501-7032 Fax: 208-501-7026 | |
Dr. Christopher K Johnson, PHARM.D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3232 Elder Street, Boise, ID 83705 Phone: 208-364-1829 Fax: 180-032-7554 | |
Dr. Catherine M Oliphant, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 300 E Jefferson St, Suite 201, Boise, ID 83712 Phone: 208-381-4146 Fax: 208-381-1665 |